PAXgene Blood RNA Extraction, Quantitation, Normalization, Agilent Quality Control, and Aliquoting Services

PresolicitationNo Set AsideActive

Key Takeaways

  • Set-aside for No Set Aside businesses
  • Work to be performed in BETHESDA, MD
  • Industry: Research and Development in Biotechnology (except Nanobiotechnology)
  • Advance notice of upcoming solicitation

Contract Details

Notice ID
75N98026Q00701
Opportunity Type
Presolicitation
Sub-Agency
NATIONAL INSTITUTES OF HEALTH
Office
NATIONAL INSTITUTES OF HEALTH OLAO
Posted Date
Wednesday, June 24, 2026
Response Deadline
Monday, July 6, 2026
PSC Code
Q301
Set-Aside
No Set Aside
Place of Performance
BETHESDA, MD, 20892
Status
Active

Description

General Information Document Type: Presolicitation Synopsis Number: 75N98026Q00701 Posted Date: June 24, 2026 Original Response Date: July 6, 2026 Current Response Date: July 6, 2026 Set Aside: N/A NAICS Code: 541714 Contracting Office Address National Institutes of Health (NIH), Office of the Director (OD) Office of Logistics and Operations (OLAO) Office of Acquisition and Logistics Management (OALM) Hospital and Laboratory Support Division 6701 Rockledge Drive Bethesda, MD 20817 Description INTRODUCTION THIS IS A PRE-SOLICITATION NON-COMPETITIVE (NOTICE OF INTENT) SYNOPSIS TO AWARD A CONTRACT OR PURCHASE ORDER WITHOUT PROVIDING FOR FULL OR OPEN COMPETITION (INCLUDING BRAND-NAME). The National Institutes of Health (NIH) intends to negotiate and award a contract without providing for full

Why This Opportunity Matters

HEALTH AND HUMAN SERVICES, DEPARTMENT OF is actively seeking qualified contractors for research and development in biotechnology (except nanobiotechnology) with a set-aside for No Set Aside businesses in BETHESDA, MD. This set-aside designation means eligible businesses face reduced competition from larger firms.